CLS Financial Statements From 2010 to 2024
| CLSH Stock | USD 0.04 0 6.04% |
Check CLS Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CLS Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . CLS financial statements analysis is a perfect complement when working with CLS Holdings Valuation or Volatility modules.
CLS |
CLS Holdings USA OTC Stock Operating Margin Analysis
CLS Holdings' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CLS Holdings Operating Margin | (0.05) % |
Most of CLS Holdings' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CLS Holdings USA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CLS Holdings USA has an Operating Margin of -0.0511%. This is 99.85% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 99.07% lower than that of the firm.
CLS Holdings USA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CLS Holdings's current stock value. Our valuation model uses many indicators to compare CLS Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CLS Holdings competition to find correlations between indicators driving CLS Holdings's intrinsic value. More Info.CLS Holdings USA is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CLS Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CLS Holdings' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About CLS Holdings Financial Statements
Investors use fundamental indicators, such as CLS Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although CLS Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida. Cls Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in CLS OTC Stock
CLS Holdings financial ratios help investors to determine whether CLS OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CLS with respect to the benefits of owning CLS Holdings security.